Literature DB >> 9464583

Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency.

A Henderson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9464583     DOI: 10.1016/s0167-5273(97)00212-x

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Clinical implications of physiological changes in the aging heart.

Authors:  K G Pugh; J Y Wei
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1).

Authors:  Hiroshi Nomoto; Hideaki Miyoshi; Tomoo Furumoto; Koji Oba; Hiroyuki Tsutsui; Atsushi Inoue; Tatsuya Atsumi; Naoki Manda; Yoshio Kurihara; Shin Aoki
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

3.  The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).

Authors:  Naoyuki Kitao; Hideaki Miyoshi; Tomoo Furumoto; Kota Ono; Hiroshi Nomoto; Aika Miya; Chiho Yamamoto; Atsushi Inoue; Kenichi Tsuchida; Naoki Manda; Yoshio Kurihara; Shin Aoki; Akinobu Nakamura; Tatsuya Atsumi
Journal:  Cardiovasc Diabetol       Date:  2017-10-10       Impact factor: 9.951

4.  There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients.

Authors:  Mariana Nogueira Coutinho; Aluizio Barbosa Carvalho; Maria Aparecida Dalboni; Margaret Gori Mouro; Elisa Mieko Suemitsu Higa; Valéria Costa-Hong; Luiz Aparecido Bortolotto; Rejane Augusta de Oliveira Figueiredo; Maria Eugênia Fernandes Canziani
Journal:  J Diabetes Res       Date:  2018-11-25       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.